Centogene NV
NASDAQ:CNTG
Centogene NV
Gross Profit
Centogene NV
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
Gross Profit
€19.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Gross Profit
€3.2B
|
CAGR 3-Years
97%
|
CAGR 5-Years
95%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Gross Profit
€170.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Gross Profit
€280.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
16%
|
CAGR 10-Years
3%
|
|
Formycon AG
XETRA:FYB
|
Gross Profit
€22.9m
|
CAGR 3-Years
44%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Gross Profit?
Gross Profit
19.9m
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's Gross Profit amounts to 19.9m EUR.
What is Centogene NV's Gross Profit growth rate?
Gross Profit CAGR 5Y
4%
Over the last year, the Gross Profit growth was 37%. The average annual Gross Profit growth rates for Centogene NV have been -4% over the past three years , 4% over the past five years .